Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Novocure Ltd (NVCR)  
$22.32 0.83 (3.59%) as of 4:30 Tue 5/28


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 101,800,000
Market Cap: 2.27(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $11.13 - $82.51
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   NovoCure is an oncology company with a platform technology called Tumor Treating Fields. Co. is focusing on commercial adoption of Optune and NovoTTF-100L. Optune is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) in combination with temozolomide, a chemotherapy drug, and for adult patients with GBM following confirmed recurrence after chemotherapy as monotherapy treatment. Co. also has approval to market Optune for the treatment of GBM in the European Union, Japan and certain other countries. NovoTTF-100L is approved by the FDA to treat malignant pleural mesothelioma in combination with chemotherapies.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 5,843 10,224 13,200 434,026
Total Sell Value $93,610 $164,332 $235,406 $41,239,900
Total People Sold 2 2 4 10
Total Sell Transactions 4 6 11 52
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 906
  Page 16 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Longsworth Todd Christopher General Counsel   •       –      –    2020-03-03 4 A $0.00 $0 D/D 19,220 89,252     -
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-03-03 4 A $0.00 $0 D/D 14,415 223,141     -
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-03-02 4 AS $72.97 $108,360 D/D (1,485) 67,721 -19%     
   Groenhuysen Wilhelmus Cm Chief Operating Officer   •       –      –    2020-02-28 4 S $72.22 $265,029 D/D (3,670) 150,014 17%     
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-02-28 4 S $72.22 $193,031 D/D (2,673) 208,726 17%     
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-02-28 4 S $72.22 $115,616 D/D (1,601) 69,206 17%     
   Doyle William F Executive Chairman   •       •      –    2020-02-28 4 S $72.22 $281,133 D/D (3,893) 514,831 17%     
   Longsworth Todd Christopher General Counsel   •       –      –    2020-02-28 4 S $72.22 $190,864 D/D (2,643) 70,032 17%     
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-02-27 4 OE $79.45 $490,445 D/D 6,173 211,399     -
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-02-27 4 OE $79.45 $245,183 D/D 3,086 70,807     -
   Doyle William F Executive Chairman   •       •      –    2020-02-27 4 OE $79.45 $735,628 D/D 9,259 518,724     -
   Danziger Asaf Chief Executive Officer   •       •      –    2020-02-27 4 OE $79.45 $735,628 D/D 9,259 197,348     -
   Groenhuysen Wilhelmus Cm Chief Financial Officer   •       –      –    2020-02-27 4 OE $0.00 $0 D/D 7,716 119,484     -
   Longsworth Todd Christopher General Counsel   •       –      –    2020-02-27 4 OE $79.45 $441,424 D/D 5,556 72,675     -
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-02-26 4 AS $78.68 $629,725 D/D (7,932) 67,721 -29%     
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-02-25 4 AS $81.16 $411,217 D/D (5,067) 75,653 -25%     
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-02-25 4 S $81.16 $945,224 D/D (11,647) 205,226 25%     
   Groenhuysen Wilhelmus Cm Chief Financial Officer   •       –      –    2020-02-25 4 S $81.16 $1,534,498 D/D (18,908) 111,768 25%     
   Longsworth Todd Christopher General Counsel   •       –      –    2020-02-25 4 S $81.16 $688,365 D/D (8,482) 67,119 25%     
   Ambrogi Michael J. Chief Operating Officer   •       –      –    2020-02-24 4 OE $88.26 $2,753,624 D/D 31,199 216,873     -
   Groenhuysen Wilhelmus Cm Chief Financial Officer   •       –      –    2020-02-24 4 OE $88.26 $3,824,571 D/D 43,333 130,676     -
   Danziger Asaf Chief Executive Officer   •       •      –    2020-02-24 4 OE $88.26 $4,707,171 D/D 53,333 188,089     -
   Longsworth Todd Christopher General Counsel   •       –      –    2020-02-24 4 OE $88.26 $1,912,241 D/D 21,666 75,601     -
   Shah Pritesh Chief Commercial Officer   •       –      –    2020-02-24 4 OE $88.26 $1,147,292 D/D 12,999 80,720     -
   Groenhuysen Wilhelmus Cm Chief Financial Officer   •       –      –    2020-01-22 4 AS $98.11 $286,084 D/D (2,915) 87,343 -31%     
  906 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 16 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us